Prosecution Insights
Prosecution Insights
Tech Center 2800 • Art Units: 1600 1654 1677 1678 2818
This examiner grants 0% of resolved cases
Elizabeth Bisola Oguntade is an examiner assigned to Tech Center 2800 and Art Unit 1600. The examiner has a total of 1 resolved case in the current data set. This single resolved case means the statistical sample for this examiner is limited. Practitioners should view the following percentages as a reflection of this specific outcome rather than a broad trend across many years of examination.
The allowance rate for this examiner is 0.0 percent. This figure is derived from the 1 resolved case that resulted in abandonment rather than a grant. Similarly, the interview lift is 0.0 percent. This lift indicates that for the case resolved, an interview did not result in a change to the final outcome. Applicants should consider that these figures may change significantly as the examiner resolves more applications in the future.
The median days to allowance is 629. This 629 day figure represents the time associated with the prosecution of the case in the record. Even with an allowance rate of 0.0 percent, the 629 day metric provides a data point for the duration of the examination process under this examiner. Practitioners working in Art Unit 1600 should monitor how these metrics evolve as the examiner's total resolved cases increases over time.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18700260 | DHEAS ASSAY, REAGENTS FOR SAME, AND METHODS OF PRODUCTION AND USE THEREOF | Non-Final OA | Siemens Healthcare Diagnostics Inc. |
| 18575591 | METHODS OF DETERMINING RISK OF AND TREATING CANCER RECURRENCE | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF MICHIGAN |
| 18578564 | REAGENT FOR PREPARING A CELL SAMPLE | Non-Final OA | SONY GROUP CORPORATION |
| 18608596 | POLYMER-COATED GLASS SUBSTRATE | Non-Final OA | SUMITOMO RUBBER INDUSTRIES, LTD. |
| 17630104 | METHODS AND COMPOSITIONS FOR HEPATITIS C VIRUS (HCV) | Non-Final OA | The Johns Hopkins University |
| 18681989 | DETECTION OF BIOACTIVE AGENTS IN A SURROUNDING MEDIUM | Non-Final OA | Philip Morris Products S.A. |
| 18376575 | LUNG CANCER BIOMARKERS | Final Rejection | Meso Scale Technologies, LLC. |
| 17413368 | MULTIPLEXED ASSAY | Final Rejection | OSLER DIAGNOSTICS LIMITED |
| 18280706 | ARTIFICIAL TARGET FOR ANTIGEN-SPECIFIC ACTIVATION AND EXPANSION OF CAR T CELLS | Final Rejection | Miltenyi Biotec B.V. & Co KG |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy